help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 14, 2003
Endocrinology, doi:10.1210/en.2003-1290
A more recent version of this article appeared on February 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
145/2/650    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, C.
Right arrow Articles by Lange, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, C.
Right arrow Articles by Lange, A. J.

Submitted on September 26, 2003
Accepted on November 3, 2003

A Potential Role for Fructose-2,6-bisphosphate in the Stimulation of Hepatic Glucokinase Gene Expression

Chaodong Wu1, David A. Okar1, Angela K. Stoeckman1, Li-Jen Peng1, Amy H. Herrera1, Julio E. Herrera1, Howard C. Towle1, and Alex J. Lange1*

1 Department of Biochemistry, Molecular Biology and Biophysics, Medical School, University of Minnesota, 6-155 Jackson Hall, 321 Church Street SE, Minneapolis, Minnesota 55455, USA; Veterans Administration Medical Center, 1 Veterans Drive, Minneapolis, MN 55417, USA.

* To whom correspondence should be addressed. E-mail: lange024{at}umn.edu.

The effects of fructose-2,6-bisphosphate on hepatic glucokinase and glucose-6-phosphatase gene expression were investigated in streptozotocin-treated mice, which exhibited undetectable levels of insulin. Hepatic fructose-2,6-bisphosphate levels were manipulated by adenovirus-mediated overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Streptozotocin treatment alone or with infusion of control adenovirus leads to a dramatic decrease in hepatic fructose-2,6-bisphosphate content compared with normal nondiabetic mice. This is accompanied by a 14-fold decrease in glucokinase and a 3-fold increase in glucose-6-phosphatase protein levels, consistent with a diabetic phenotype. Streptozotocin-treated mice that were infused with adenovirus-overexpressing an engineered 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase with high kinase activity and little bisphosphatase activity showed high levels of hepatic fructose-2,6-bisphosphate. Surprisingly, these mice had a 13-fold increase in glucokinase protein and a 2-fold decrease in glucose-6-phosphatase protein compared with diabetic controls. The restoration of glucokinase is associated with increases in the phosphorylation of Akt upon increasing hepatic fructose-2,6-bisphosphate content. Moreover, the changes in levels of fructose-2,6-bisphosphate and Akt phosphorylation revealed a pattern similar to that of streptozotocin mice treated with insulin, indicating that increasing hepatic content of fructose-2,6-bisphosphate mimics the action of insulin. Since glucose-6-phosphatase gene expression was down-regulated only after the restoration of euglycemia, the effect of fructose-2,6-bisphosphate was indirect. Also, the lowering of blood glucose by high fructose-2,6-bisphosphate was associated with an increase in hepatic nuclear factor 1-{alpha} protein, a transcription factor involved in glucose-6-phosphatase gene expression. In conclusion, fructose-2,6-bisphosphate can stimulate hepatic glucokinase gene expression in an insulin-independent manner and can secondarily affect glucose-6-phosphatase gene expression by lowering the level of plasma glucose.


Key words: fructose-2,6-bisphosphate • insulin • glucokinase • glucose-6-phosphatase • type 1 diabetes




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Wang, R. V. Donthi, J. Wang, A. J. Lange, L. J. Watson, S. P. Jones, and P. N. Epstein
Cardiac phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxia
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2889 - H2897.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. S. Freitas, G. F. Anhe, K. F. S. Melo, M. M. Okamoto, M. Oliveira-Souza, S. Bordin, and U. F. Machado
Na+-Glucose Transporter-2 Messenger Ribonucleic Acid Expression in Kidney of Diabetic Rats Correlates with Glycemic Levels: Involvement of Hepatocyte Nuclear Factor-1{alpha} Expression and Activity
Endocrinology, February 1, 2008; 149(2): 717 - 724.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. E. Smith, S. Langer, C. Wu, S. Baltrusch, and D. A. Okar
Molecular Coordination of Hepatic Glucose Metabolism by the 6-Phosphofructo-2-Kinase/Fructose-2,6- Bisphosphatase:Glucokinase Complex
Mol. Endocrinol., June 1, 2007; 21(6): 1478 - 1487.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Corrigendum
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E370 - E370.
[Full Text] [PDF]


Home page
EndocrinologyHome page
S. Baltrusch, S. Langer, L. Massa, M. Tiedge, and S. Lenzen
Improved Metabolic Stimulus for Glucose-Induced Insulin Secretion through GK and PFK-2/FBPase-2 Coexpression in Insulin-Producing RINm5F Cells
Endocrinology, December 1, 2006; 147(12): 5768 - 5776.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Wu, S. A. Khan, L.-J. Peng, H. Li, S. G. Carmella, and A. J. Lange
Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia
Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E536 - E543.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. A. Payne, C. Arden, C. Wu, A. J. Lange, and L. Agius
Dual Role of Phosphofructokinase-2/Fructose Bisphosphatase-2 in Regulating the Compartmentation and Expression of Glucokinase in Hepatocytes
Diabetes, July 1, 2005; 54(7): 1949 - 1957.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
X.-L. Cui, A. M. Schlesier, E. L. Fisher, C. Cerqueira, and R. P. Ferraris
Fructose-induced increases in neonatal rat intestinal fructose transport involve the PI3-kinase/Akt signaling pathway
Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1310 - G1320.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. A. Baar, C. S. Dingfelder, L. A. Smith, D. A. Bernlohr, C. Wu, A. J. Lange, and E. J. Parks
Investigation of in vivo fatty acid metabolism in AFABP/aP2-/- mice
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E187 - E193.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. V. Donthi, G. Ye, C. Wu, D. A. McClain, A. J. Lange, and P. N. Epstein
Cardiac Expression of Kinase-deficient 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase Inhibits Glycolysis, Promotes Hypertrophy, Impairs Myocyte Function, and Reduces Insulin Sensitivity
J. Biol. Chem., November 12, 2004; 279(46): 48085 - 48090.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. J. Collier and D. K. Scott
Sweet Changes: Glucose Homeostasis Can Be Altered by Manipulating Genes Controlling Hepatic Glucose Metabolism
Mol. Endocrinol., May 1, 2004; 18(5): 1051 - 1063.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society